比利時Pronota NV
Pronota 正在研發一種新的血液診斷方法,此方法將用于心腎綜合癥及婦科疾病的診斷(先兆子癇,卵巢癌 。我們這種獨特的研究方法是以血液中多種不同的蛋白質為標志物來斷定身體的疾病狀態、 疾病危險并做疾病預測。
Pronota is using its unique protein biomarker discovery technologies to develop a valuable pipeline of high value diagnostic tests. Because we start with no a priori assumptions about the identity of candidate biomarkers, and because our technology allows us to search for diagnostic biomarkers present in very low amounts in blood, we generate large numbers of novel, highly patentable, candidates with valuable diagnostic utility. Our lead programs are in the cardio-renal area and women’s health where we are developing tests that have the potential to make the same clinical and commercial impact as have the diagnostic blockbusters BNP and NT-proBNP.